19 February 2020
Human trials for one or two of the most promising vaccine candidates could begin in three or four months, WHO chief scientist Soumya Swaminathan said.
She added that WHO experts, who gathered for a two-day forum in Geneva earlier this week, have discussed possible timeframes for determining what vaccine should be a priority.
In her opinion, the new vaccine expected to be ready in 12-18 months.
On February 11 and 12, Geneva hosted a two-day global forum aimed at establishing measures to fight the novel coronavirus. The forum brings together around 400 experts from across the world. The main goal of the forum is to identify knowledge gaps and research priorities in order to produce scientific information and medical products most needed to minimize the impact of the outbreak.
PrintMerry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
Enhancing spectroscopy analysis with machine learning
03 February 2025
The production of new Russian “super antibiotic” to begin in Novosibirsk
03 February 2025
A Russian company has started producing 4 veterinary vaccines
31 January 2025
The government held its first meeting on the “New technologies for preserving health” project
31 January 2025